Has Tina Rahe received payments from drug or device companies?

Yes. Drug and device makers reported $3,396 in general payments to Tina Rahe across 122 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tina Rahe did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tina Rahe come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tina Rahe

Psychiatric/Mental Health · Lake Worth, FLNPI 1235911678

Payments from drug & device makers

$3,396in general payments, 2019–2025

Across 122 payments — averaging $27.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$452
Neurocrine Biosciences, Inc.$437
Otsuka America Pharmaceutical, Inc.$397
AbbVie$355
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$342
Vanda Pharmaceuticals Inc.$248
plus $1K from 12 others

What the payments were for

Food & beverage$3,396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	17	$452
Neurocrine Biosciences, Inc.	13	$437
Otsuka America Pharmaceutical, Inc.	8	$397
AbbVie	18	$355
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$342
Vanda Pharmaceuticals Inc.	8	$248
Axsome Therapeutics, Inc.	7	$189
Takeda Pharmaceuticals U.S.A., Inc.	7	$173
E.r. Squibb & Sons, L.L.C.	2	$141
Braeburn Inc.	3	$130
Corium, LLC	6	$130
Johnson & Johnson	4	$102
Indivior Inc.	4	$85
Lundbeck LLC	4	$71
Tris Pharma Inc	3	$67
Teva Pharmaceuticals USA, Inc.	2	$33
Almatica Pharma LLC	1	$25
Livanova USA, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

REXULTI$250
INGREZZA$134
CAPLYTA$125
VRAYLAR$125
COBENFY$122
Fanapt$113
VIVITROL$100

How this compares

$3,396 in reported general payments places this provider in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	173	$7,834
Atomoxetine Hcl	14	$678
Doxepin Hcl	13	$314
Buspirone Hcl	13	$152
Bupropion XlBupropion Hcl	14	$148
Trazodone Hcl	12	$65

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Lake Worth

Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Cheedy JajaTampa$266K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K
Angela DavenportAlachua$83K
Natalie MoodyWinter Haven$75K
Kelli BridgmanNew Smyrna Beach$66K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →